NCT05139706View on ClinicalTrials.gov

Montreal Immune-Related Adverse Events (MIRAE) Study

RecruitingOBSERVATIONAL
Enrollment

1,000

Participants

Timeline

Start Date

January 21, 2020

Primary Completion Date

January 31, 2030

Study Completion Date

January 31, 2030

Conditions
CancerImmune System DisorderInflammatory ReactionAutoimmune Diseases
Trial Locations (1)

H3T 1E2

RECRUITING

Jewish General Hospital, Montreal

All Listed Sponsors
lead

Sir Mortimer B. Davis - Jewish General Hospital

OTHER